Organoids for Cancer Subtypes
August 8, 2023 | Terry Sharrer
“Since most head and neck cancer patients relapse, and there is strong evidence that subtypes exist, there is an urgent need for biomarkers to guide treatment. Now, researchers [Hubrecht Institute, Utrecht, The Netherlands] have developed a biobank of over 100 organoids, which may help clinicians choose the most appropriate treatment. These patients typically undergo surgery, radiotherapy, and/or chemotherapy.” MORE
Image Credit: InsidePrecisionMedicine and Kateryna Kon, Science Photo Library, Getty Images